Riskpilot← Back to searchSign inGet full accessSPECIALLÆGE VILMANN ApS
APSActiveCVR 29619212Ahornvej 19Medical specialists activities · NACE 8622Est. 20061 employees
Revenue 2025
DKK 284K
+9% vs 2024
EBITDA margin
57.8%
+150% vs 2024
Equity ratio
84.7%
Financial strength
Net profit 2025
DKK 120K
+133% vs 2024
| Revenue | DKK 284K | +9% |
| EBITDA | DKK 164K | +150% |
| Net profit | DKK 120K | +133% |
| Total assets | DKK 398K | +5% |
| Equity | DKK 338K | -4% |
| Employees | 1 | — |
Legal name
SPECIALLÆGE VILMANN ApS
CVR number
29619212
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
15. juni 2006
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Address
Ahornvej 19
Phone
+4561677950
Email
peter@vilmann.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 474 | 503 | 518 | 552 | 552 | 542 | 777 | 804 | 802 | 558 | 377 | 251 | 260 | 284 |
| Staff expenses | -416 | -479 | -401 | -485 | -559 | -445 | -493 | -545 | -753 | -455 | -318 | -230 | -195 | -120 |
| EBITDA | 57 | 24 | 117 | 68 | -7 | 98 | 284 | 259 | 50 | 103 | 59 | 15 | 66 | 164 |
| Depreciation & amort. | -22 | 10 | 3 | -0 | -3 | -12 | -12 | -12 | -12 | -9 | -16 | -0 | -0 | -0 |
| EBIT | 36 | 14 | 114 | 68 | -10 | 86 | 273 | 247 | 38 | 94 | 42 | 15 | 66 | 164 |
| Net financials | 3 | -1 | -1 | -0 | -1 | -1 | -2 | -2 | 15 | 72 | 20 | 30 | -3 | -10 |
| Profit before tax | 38 | 13 | 112 | 67 | -10 | 85 | 271 | 246 | 53 | 166 | 62 | 44 | 63 | 154 |
| Tax | -0 | 0 | 28 | 16 | -0 | 9 | 61 | 54 | 12 | 38 | 17 | 9 | 11 | 34 |
| Net profit | 38 | 13 | 85 | 52 | -10 | 77 | 210 | 191 | 40 | 129 | 46 | 36 | 51 | 120 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 440 | 522 | 550 | 287 | 580 | 529 | 425 | 515 | 660 | 658 | 517 | 348 | 379 | 398 |
| Equity | 107 | 119 | 204 | 186 | 125 | 202 | 306 | 389 | 319 | 334 | 265 | 301 | 353 | 338 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 333 | 403 | 346 | 101 | 455 | 327 | 120 | 126 | 342 | 324 | 251 | 47 | 26 | 61 |
| Total debt | 333 | 403 | 346 | 101 | 455 | 327 | 120 | 126 | 342 | 324 | 251 | 47 | 26 | 61 |
EBITDA margin
57.8%
This company
15.8%
Market median
+266% vs market
20122025
Equity ratio
84.7%
This company
38.2%
Market median
+122% vs market
20122025
Return on equity
35.5%
This company
18.4%
Market median
+93% vs market
20122025
Net profit margin
42.2%
This company
8.1%
Market median
+421% vs market
20122025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20122025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BP Founder | Founder | 2006 | — | — |
UN Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 | |
SPECIALLÆGE VILMANN ApS | Company | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPECIALLÆGE VILMANN ApS 
GEAbetes ApSBoard members of SPECIALLÆGE VILMANN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Pedersen Elvers | Founder | 0 companies |
| Uffe Nikolajsen | Management | 0 companies |